Human Prostate Side Population Cells Demonstrate Stem Cell Properties in Recombination with Urogenital Sinus Mesenchyme
Barbara A. Foster(Roswell Park Comprehensive Cancer Center), Wendy J. Huss(Roswell Park Comprehensive Cancer Center)
Cited by 31
Related Papers
Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade.
|PubMed|2000|427
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer
|Proceedings of the National Academy of Sciences|1997|393
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
|Proceedings of the National Academy of Sciences|1999|223